Search

Your search keyword '"Fielitz, J"' showing total 124 results

Search Constraints

Start Over You searched for: Author "Fielitz, J" Remove constraint Author: "Fielitz, J"
124 results on '"Fielitz, J"'

Search Results

1. SPSB1-mediated inhibition of TGF-β receptor-II impairs myogenesis in inflammation

3. Hidden agenda - the involvement of endoplasmic reticulum stress and unfolded protein response in inflammation-induced muscle wasting

4. ESICM LIVES 2016: part two: Milan, Italy. 1–5 October 2016

5. Pathophysiology of Cardiac AT1 and AT2 Receptors

7. Riociguat attenuates left ventricular proteome and microRNA profile changes after experimental aortic stenosis in mice

8. Inhibition of the NLRP3/IL-1β axis protects against sepsis-induced cardiomyopathy

9. Out of control: the role of the ubiquitin proteasome system in skeletal muscle during inflammation

10. Loss of muscle mass and strength in experimental chronic pancreatitis

11. Activation of Tripartite Motif Containing 63 Expression by Transcription Factor EB and Transcription Factor Binding to Immunoglobulin Heavy Chain Enhancer 3 Is Regulated by Protein Kinase D and Class IIa Histone Deacetylases

13. Stimulation of soluble guanylyl cyclase (sGC) by riociguat attenuates heart failure and pathological cardiac remodelling

14. Serum amyloid A1 mediates myotube atrophy via Toll-like receptors

18. DCAF8, a novel MuRF1 interaction partner, promotes muscle atrophy

19. HDAC4 mutations cause diabetes and induce β-cell FoxO1 nuclear exclusion

21. Intracerebral hemorrhage in ICU: is it worth treating?

22. Risk profile analysis and complications after surgery for autoimmune thyroid disease

23. Risk profile analysis and complications after surgery for autoimmune thyroid disease

24. ESICM LIVES 2016: part two

29. Up-regulation of PPARgamma in myocardial infarction.

31. Protein Kinase D Plays a Crucial Role in Maintaining Cardiac Homeostasis by Regulating Post-Translational Modifications of Myofilament Proteins.

32. Increased Expression of Proinflammatory Genes in Peripheral Blood Cells Is Associated with Cardiac Cachexia in Patients with Heart Failure with Reduced Ejection Fraction.

33. Metabolic remodeling in cardiac hypertrophy and heart failure with reduced ejection fraction occurs independent of transcription factor EB in mice.

34. Mammalian target of rapamycin inhibition impacts energy homeostasis and induces sex-specific body weight loss in humans.

35. Cardiomyocyte peroxisome proliferator-activated receptor α prevents septic cardiomyopathy via improving mitochondrial function.

36. SPSB1-mediated inhibition of TGF-β receptor-II impairs myogenesis in inflammation.

37. Longitudinal Clinical Features of Post-COVID-19 Patients-Symptoms, Fatigue and Physical Function at 3- and 6-Month Follow-Up.

38. The Greifswald Post COVID Rehabilitation Study and Research (PoCoRe)-Study Design, Characteristics and Evaluation Tools.

39. Riociguat attenuates the changes in left ventricular proteome and microRNA profile after experimental aortic stenosis in mice.

40. High-Mobility Group Box Protein 1 Is an Independent Prognostic Marker for All-Cause Mortality in Patients With Dilated Cardiomyopathy.

41. Myeloid differentiation factor-2 activates monocytes in patients with dilated cardiomyopathy.

42. Muscular myostatin gene expression and plasma concentrations are decreased in critically ill patients.

43. Stimulation of soluble guanylyl cyclase (sGC) by riociguat attenuates heart failure and pathological cardiac remodelling.

44. The Transcription Factor EB (TFEB) Sensitizes the Heart to Chronic Pressure Overload.

45. Hidden Agenda - The Involvement of Endoplasmic Reticulum Stress and Unfolded Protein Response in Inflammation-Induced Muscle Wasting.

46. Sepsis induces interleukin 6, gp130/JAK2/STAT3, and muscle wasting.

47. Skeletal muscle derived Musclin protects the heart during pathological overload.

48. Physical Performance and Non-Esterified Fatty Acids in Men and Women after Transcatheter Aortic Valve Implantation (TAVI).

49. Muscle Mass and Inflammation in Older Adults: Impact of the Metabolic Syndrome.

50. Inhibition of the NLRP3/IL-1β axis protects against sepsis-induced cardiomyopathy.

Catalog

Books, media, physical & digital resources